Home ›
Organizations ›
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
SC · Medical Research · EIN 475407453
48
Executives Disclosed
$585K
Annual Revenue
$84K
Total Assets
4.2:1
Internal Pay Ratio
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH has 48 executives with disclosed compensation. The highest-paid executive, Wael Haidar Md (Board Member, BSMH CHIEF CLINICAL OFFICER), received peak total compensation of $2,562,363. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Wael Haidar | Board Member, BSMH CHIEF CLINICAL OFFICER | $2.6M | $2.5M | 2020–2024 | 34.2x |
| Jeffrey Dilisi | Former President/CEO RSFH | $2.1M | $2.1M | 2020–2024 | 27.6x |
| Brian White | Board Member (End 03/20); Atlantic Group President - BSMH | $2.0M | $2.0M | 2020–2020 | 26.8x |
| Joseph Gage | Board Member, BSMH Chief HR Officer | $1.8M | $1.8M | 2020–2024 | 23.7x |
| David Dunlap | President & CEO of CAHS (through Oct) | $1.6M | $1.6M | 2016–2016 | 21.6x |
| Lorraine Lutton | Former CEO | $1.5M | $1.4M | 2016–2020 | 20.2x |
| Michael Lutes | Board Member (Beg 05/2024), Richmond Market President - BSMH | $1.4M | $1.4M | 2024–2024 | 19.1x |
| Scott Woodfield | Board Vice Chair, RSFPP Physician | $1.2M | $1.2M | 2023–2024 | 16.3x |
| Brian Cuddy | Former Chairperson, Neurosurgeon - RSFPP | $1.2M | $1.2M | 2016–2024 | 15.8x |
| Lutton Lorraine | President & CEO - RSFH | $1.1M | $1.0M | 2017–2018 | 14.8x |
| Severance Matthew | COO RSFH & CEO Roper Hospital | $1.1M | $724K | 2017–2018 | 14.4x |
| Eric Smith | Board Member (Beg 05/2024), CFO Ambulatory Finance - BSMH | $1.0M | $1.0M | 2024–2024 | 13.5x |
| Matthew Severance | SVP Operations & CEO, Roper Hospital | $1.0M | $1.0M | 2016–2016 | 13.4x |
| Megan Baker | Board Member (End 08/24); Interim President RSF Foundation (Beg 10/24) | $980K | $980K | 2023–2024 | 13.1x |
| Johnson Bret | SVP & CFO/Treasurer - RSFH | $974K | $974K | 2017–2017 | 13x |
| John Spratt | Board Member, Physician | $963K | $951K | 2023–2024 | 12.8x |
| Bret Johnson | CFO & SVP / Treasurer | $923K | $923K | 2016–2016 | 12.3x |
| John A Spratt | Board Member (See Sch O) | $883K | $883K | 2016–2016 | 11.8x |
| Bret D Johnson | Former CFO & SVP / Treasurer | $831K | $306K | 2018–2021 | 11.1x |
| Edwards Gregory | VP & General Counsel | $766K | $601K | 2017–2018 | 10.2x |
| Henry West | Board Member (Beg 01/24), Surgeon - RSFPP | $757K | $591K | 2019–2024 | 10.1x |
| Adriana Day | CFO/Treasurer RSFH (End 09/23) | $751K | $528K | 2021–2023 | 10x |
| Brian Yanofchick | Board Member, Chief Sponsorship Officer-BSMH | $740K | $740K | 2020–2024 | 9.9x |
| Gregory Edwards | VP & General Council/ Secretary | $679K | $679K | 2016–2016 | 9x |
| Cheryl Dalton-Norman | Board Member (Beg 05/2024), President - Conduit Health Partners | $620K | $620K | 2024–2024 | 8.3x |
| Joseph Deleon | President/CEO RSFH (Beg 08/24) | $602K | $602K | 2024–2024 | 8x |
| Brad Grosteffon | Interim CFO/Treasurer (End 08/24) | $585K | $585K | 2023–2024 | 7.8x |
| James Berg | Interim CEO (Beg 01/20 - End 12/20) | $576K | $576K | 2020–2020 | 7.7x |
| Wills C Geils | Board Member, Oncology Physician | $568K | $568K | 2016–2022 | 7.6x |
| Porter Stephen | President CBRI | $533K | $533K | 2018–2018 | 7.1x |
| John B Holloway | Board Member, CEO - MSSC | $500K | $495K | 2016–2020 | 6.7x |
| Johnathan Donaldson | Board Member (Beg 05/23; End 08/23), Physician | $450K | $450K | 2023–2023 | 6x |
| Susan Datta | Board Member (End 12/24), Internist - RSFPP | $446K | $433K | 2016–2024 | 5.9x |
| Neuman Keith | VP & CIO | $423K | $423K | 2017–2018 | 5.6x |
| Jacobo Mintzer | Executive Director, Chief Research Officer | $420K | $420K | 2016–2020 | 5.6x |
| Stephen Porter | President/CEO/COO - CBRI (End 02/19) | $403K | $403K | 2019–2019 | 5.4x |
| Christopher Glenn | Former Interim CFO/Treasurer | $357K | $326K | 2020–2023 | 4.8x |
| Francis Wyckoff | Former Key, Director of Pharmacy | $307K | $266K | 2016–2021 | 4.1x |
| Wyckoff Francis | Director of Pharmacy | $280K | $280K | 2017–2018 | 3.7x |
| Rebecca Tucker | CFO/Treasurer (Beg 08/24) | $262K | $262K | 2024–2024 | 3.5x |
| Dunlap David | Former Officer | $232K | $232K | 2017–2017 | 3.1x |
| Andrea Marshall | Director Innovation Center | $205K | $201K | 2016–2020 | 2.7x |
| Marshall Andrea | Dir Innovation Center | $198K | $198K | 2017–2018 | 2.6x |
| Bree Maddray | Lead RN Clinical Research | $183K | $183K | 2024–2024 | 2.4x |
| Julia Johnson | Research Manager | $131K | $0 | 2024–2024 | 1.7x |
| Melissa May | Nurse Practitioner | $117K | $0 | 2020–2020 | 1.6x |
| Kent Stock | Board Member | $25K | $0 | 2019–2019 | 0.3x |
| Alison E Dillon | Vice Chair (See Sch O) | $9K | $0 | 2016–2016 | 0.1x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 14 | $703K | $1.6M | $7.7M |
| 2017 | 9 | $591K | $1.1M | $5.3M |
| 2018 | 9 | $538K | $1.0M | $4.8M |
| 2019 | 12 | $622K | $1.5M | $6.2M |
| 2020 | 18 | $845K | $2.0M | $12.7M |
| 2021 | 12 | $760K | $2.0M | $8.4M |
| 2022 | 10 | $1.0M | $2.6M | $10.4M |
| 2023 | 13 | $854K | $2.3M | $11.1M |
| 2024 | 18 | $1.0M | $2.5M | $17.2M |
Email Alerts
Get notified about CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.